Great hopes are also placed in the therapeutic application of VEGF–VEGFR-modulations for spinocerebellar ataxia 1 (SCA1) [32], as well as in traumatic brain injuries such as stroke [31,51] or epilepsy [30]. The gene discussed is VEGFA; the disease is spinocerebellar ataxia type 1.